Kento Health

What Kento Health does

Kento Health is a Montreal-headquartered, Delaware-incorporated digital therapeutics company founded in 2023 that builds a precision, AI-powered continuous cardiovascular monitoring and care platform. The platform combines always-on signal capture (vitals, wearable streams, symptoms, and behavior) with a proprietary model portfolio — nine specialized models orchestrated by a clinical orchestrator called KAI — that covers ventilatory threshold detection (KENTO|BREATHE), R-peak detection (KENTO|QRS), multi-class ECG abnormality classification across 37 conditions, cardiac and vascular age estimation, arrhythmia prediction, treatment-pathway optimization, and beat-to-beat cardiac mechanics from ballistocardiography (KENTO|BCG). A clinician interface (KORE) and a patient mobile app (iOS and Android) deliver the outputs as daily adaptive care plans, AI-drafted documentation, risk alerts, and decision support.

Kento serves three primary customer segments: health systems and hospitals (delivered as a SaaS platform embedded into EMRs and clinical workflows), insurers and health plans (positioned as a turnkey population-health tool to prevent costly cardiac events), and individual patients (self-serve via a freemium "Try Now Free" mobile app). It also markets to employers as a secondary segment. The commercial motion is hybrid: enterprise field sales into providers and payers, supported by a co-development and distribution relationship with Mayo Clinic via the Mayo Clinic Platform Solutions Studio, paired with product-led growth through the consumer app stores.

The business model is B2B SaaS subscription licensing to health systems, hospitals, and insurers, with an additional delegated-care services revenue stream in which Kento supplies licensed clinicians on top of the software. Pricing is not publicly disclosed; the consumer app runs on a freemium trial basis. Clinical validation is anchored by a Mayo Clinic deployment in Cardiovascular Medicine (Rochester, MN, Feb 2026), a Henry Ford Health clinical study (March 2024–May 2025), and a peer-reviewed publication in the Journal of Cardiopulmonary Rehabilitation & Prevention reporting 75% fewer readmissions and 93% blood pressure control. Kento has raised a pre-seed round led by Boreal Ventures and N49P (Oct 2023) plus follow-on capital from Amplify Capital (Feb 2025) and operates with 11–50 employees.

Name

Kento Health

Legal name

Kento Health Inc.

Website

https://kentohealth.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Kento Health is a precision digital therapeutics company that builds an AI-powered continuous cardiovascular monitoring platform for health systems, insurers, and cardiac patients. Co-developed with Mayo Clinic, the SaaS platform delivers hybrid cardiac rehabilitation, predictive risk scoring, and clinician decision support.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Home Health Care Services (62161), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Digital therapeutics
• Cardiac rehabilitation platform
• Cardiovascular care software
• Remote patient monitoring
• Clinical decision support

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Platform Licensing: Kento Health operates as a SaaS platform that health systems subscribe to for cardiovascular and pulmonary care delivery. Can be deployed as software integrated into existing clinical workflows or operated as a standalone platform. Revenue generated through subscription-based licensing to health systems, hospitals, and insurers.
2. Delegated Care Services: Supports delegated-care operating models where Kento provides clinical services through licensed healthcare professionals. Leverages proprietary AI to help teams scale programs with less operational burden, generating revenue through service delivery fees.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Kento Health operates a precision digital therapeutics platform for cardiovascular and cardiopulmonary care, delivered as a SaaS product to health systems, hospitals, insurers, and health plans. The platform combines proprietary AI models (an orchestrator plus specialized predictive models) with continuous monitoring of vitals, wearables, symptoms, and behavioral signals to deliver personalized care plans, clinician decision support, and automated documentation. It also offers a patient-facing mobile app for daily adaptive support and 24/7 access to care, and supports delegated-care operating models where licensed clinicians deliver services through the platform.

Product overview

Kento Health offers a modular digital health platform for cardiovascular and cardiopulmonary care. The core Kento Platform connects patients and clinicians across in-person and remote care, deployable as software integrated into existing clinical workflows or as a standalone platform. The ecosystem includes the KORE Clinician Platform for clinical oversight and automation, a Patient App for daily adaptive support, and KAI as the AI orchestration layer. The platform features 9 proprietary AI models (KAI plus 8 specialized models) including KENTO | BREATHE (ventilatory threshold detection), KENTO | QRS (R-peak detection), and the KENTO | Predict family (cardiac/vascular age, abnormalities, arrhythmia, pathway prediction). The Continuous Cardiopulmonary Care Platform, deployed at Mayo Clinic, extends these capabilities specifically for hybrid cardiac rehabilitation.

Differentiator

Problem solved

Functional benefit

Products and services

• Kento Platform Modular digital health platform for cardiovascular and cardiopulmonary care that connects patients and clinicians across in-person and remote care. Deployable as software integrated into existing clinical workflows or as a standalone platform, sold to health systems, hospitals, insurers, and health plans.
• KORE Clinician Platform Clinician-facing dashboard providing AI-powered monitoring, real-time risk alerts, clinical decision support, automated note and Individualized Treatment Plan drafting, EMR integration, and smart recommendations for assignments and escalations. Sold to healthcare provider organizations.
• Kento Patient App Consumer-facing mobile application (iOS and Android) providing patients with a single daily plan, clear actions, adaptive coaching that adjusts to physiological and behavioral signals, and 24/7 access to care across exercise, nutrition, stress, medication, and education.
• Continuous Cardiopulmonary Care Platform Cardiopulmonary care platform supporting hybrid cardiac rehabilitation with workflows integrated into electronic medical record systems, continuous monitoring between visits, and clinician tools that reduce administrative workload through automated documentation and clinical decision support. Deployed at Mayo Clinic.

Quantifiable outcome

• 75% fewer hospital readmissions
• +8 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core and major.

• Mayo CliniccoreStrategic or Co-development Partner · 17 July 2024Know-how agreement to co-develop digital heart disease solution democratizing cardiac rehabilitation for acute and chronic care. Kento's AI-driven virtual cardiac rehabilitation platform combined with Mayo Clinic's medical expertise through shared vision of equity and patient-centered care. Solution evaluated and deployed through Mayo Clinic Platform Solutions Studio.
• Henry Ford HealthmajorStrategic or Co-development PartnerClinical study partnership providing validation data for clinical outcomes. Data from Henry Ford Health study (March 2024–May 2025) used for hospitalization reduction, operational efficiency, and financial impact metrics.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Biofourmis: Biofourmis is an AI-powered remote monitoring and digital therapeutics platform focused on chronic conditions including heart failure and cardiovascular disease, sold to health systems and payers. It is the closest analog to Kento in combining AI biosignal analytics, clinical decision support, and care delivery into a single enterprise platform.
• Moving Analytics: Moving Analytics offers a virtual cardiac rehabilitation platform used by health systems and payers to deliver home-based post-event cardiac rehab. It directly competes with Kento's continuous cardiopulmonary care platform in the same use case (post-acute cardiac rehab) and customer segments.
• Heartbeat Health: Heartbeat Health is a virtual-first cardiovascular care platform combining remote monitoring, tele-cardiology, and AI-enabled clinical workflows. It targets the same payer and health system customers and overlaps with Kento's CV-spectrum positioning.
• Vivify Health: Vivify Health (now part of Optum) provides a connected health platform for remote patient monitoring and chronic care management, integrated with EMRs and sold to health systems and payers. It is a comparable enterprise RPM and patient engagement platform serving similar cardiovascular and chronic disease use cases.
• Force Therapeutics: Force Therapeutics is a digital care platform for musculoskeletal and cardiac rehabilitation, sold to health systems with measurable outcomes on adherence and readmissions. It overlaps with Kento's value proposition of remote, video-based, AI-supported care pathways for post-acute cardiac patients.

Broad incumbents

• iRhythm Technologies: iRhythm Technologies is a publicly traded cardiac ambulatory monitoring company (Zio patch) offering FDA-cleared AI ECG analysis at scale to health systems. As a larger, established player it competes in cardiac diagnostics and monitoring with broader reach but a narrower product line than Kento's full-spectrum platform.
• Eko Health: Eko Health builds AI-powered digital stethoscopes and cardiac analytics with FDA-cleared algorithms for arrhythmia and murmur detection. It is a broader incumbent in AI cardiac diagnostics with overlapping ECG AI capabilities (e.g., KENTO|QRS is positioned against Eko's detectors).
• AliveCor: AliveCor produces KardiaMobile consumer and clinical ECG devices plus AI algorithms for arrhythmia detection, sold across consumer, provider, and payer channels. It is a comparable AI ECG player but is more focused on consumer hardware and single-lead rhythm analysis versus Kento's full-spectrum CV platform.
• Omada Health: Omada Health is a publicly listed digital chronic care platform (diabetes, hypertension, MSK) sold to payers and employers with outcomes-based contracts. While not cardiac-specific, it is a comparable DTx/SaMD platform demonstrating the payer-sponsored virtual care model Kento targets for its insurer segment.

Emerging players

• PhysIQ: PhysIQ applies AI to continuous wearable biosensor data to detect physiological changes for clinical and pharma applications, including heart failure decompensation. It overlaps with Kento's BCG and Predict decompensation models as a more general-purpose continuous biosignal AI platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/kento-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kento Health